Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061592

SVP & Chief Financial Officer returned 6,698 shares (to the company)

  • SVP & Chief Financial Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Labrucherie Gil M · SVP & Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Grant or award : show line 1 in the form +20,000 83,414 D
2017-11-16 Returned to the company : show line 2 in the form −6,698 $44.23 $296,253 76,716 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-11-15 Grant or award : show line 3 in the form Stock Option +50,000 50,000 D
Loading xslF345X03/doc4.xml…